Breakwater Capital Group Astrazeneca PLC Transaction History
Breakwater Capital Group
- $496 Billion
- Q3 2024
A detailed history of Breakwater Capital Group transactions in Astrazeneca PLC stock. As of the latest transaction made, Breakwater Capital Group holds 3,176 shares of AZN stock, worth $214,761. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,176
Previous 2,653
19.71%
Holding current value
$214,761
Previous $207 Million
19.59%
% of portfolio
0.05%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.25 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.84 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.52 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.49 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.29 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $210B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...